IL17A and myasthenia gravis: Noninvasive inflammatory markers, such as C-reactive protein (CRP), interleukin-6 (IL-6), interleukin-17 (IL-17), tumor necrosis factor-α (TNF-α), have been tested to reflex inflammatory status in MG patients [4–6].